Nitrosamine Impurities Affecting Drug-Drug Interaction Studies – Learn More

Thank you for visiting us at DIA 2024

Enter for your chance to win a reMarkable Tablet.

Please find below some of our latest resources that highlight our experience and expertise as a full service early phase CRO.
Don’t forget to complete the entry form for your chance to win a reMarkable Tablet.

Fact Sheet


Celerion Overview

Learn More

Fact Sheet


Product Labeling Studies

Learn More

Fact Sheet


Lincoln Overview

Learn More

Fact Sheet


Leverage Our Regulatory Experts for Pre-IND and IND Support

Learn More

Fact Sheet


Biomarker Excellence

Learn More

Fact Sheet


Phoenix Overview

Learn More

Article


The Impact of N-nitrosamine Impurities on Clinical Drug Development

Learn More

Article


Prevalence of Baseline Cardiac Arrhythmias

Learn More

Whitepaper


Refining Transporter DDI Studies with Endogenous Biomarkers

Learn More

Scientific Poster


What to Expect from a Phenytoin Drug-Drug Interaction Study

Learn More

Fact Sheet


ADME Studies and Radiolabeled Capabilities

Learn More

Fact Sheet


Leverage Our Renal/Hepatic PK Study Experience & Expertise

Learn More
remarkable tablet

Enter to win a reMarkable Tablet.

For additional marketing literature and thought leadership content please visit our Resource Center.